A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation


Karacay O., Sepici-Dincel A., Karcaaltincaba D., Sahin D., YALVAÇ E. S. , Akyol M., ...More

DIABETES RESEARCH AND CLINICAL PRACTICE, vol.89, no.3, pp.231-238, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 89 Issue: 3
  • Publication Date: 2010
  • Doi Number: 10.1016/j.diabres.2010.04.015
  • Journal Name: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.231-238
  • Keywords: Preeclampsia, Gestational diabetes mellitus, Advanced oxidation protein product, Antioxidant status, Myeloperoxidase, Lipid peroxidation products, FERROUS ION OXIDATION, LIPID-PEROXIDATION, PROTEIN PRODUCTS, XYLENOL ORANGE, NO EVIDENCE, PREGNANCY, CAPACITY, HYDROPEROXIDES, BLOOD
  • Yozgat Bozok University Affiliated: No

Abstract

Objective: To assess the plasma and serum maternal total antioxidant status, circulating levels of lipid peroxidation breakdown products (MDA), protein oxidation markers (AOPPs), myeloperoxidase (MPO) and lipid hydroperoxide (LHP) in preeclampsia, gestational diabetes mellitus (GDM) patients and compare them with noncomplicated normal pregnancies between 24 and 36 weeks of gestation.